Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

BTHE

Boston Therapeutics Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

BTHE:Boston Therapeutics Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$0.05

EXCHANGE

OTCBB

SECTOR

Health Care

BTHE
Boston Therapeutics Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
BTHE
Boston Therapeutics Inc Stock Information
Latest Close Price$0.05
52-Week Low/High$0.01 - $0.12
Percent Held by Institutions0.00%
Revenue$45,232
Net Income$-3,993,743
Cash Flow$-269,357
EPS0.00%
Market Cap$4,955,895
PE Ratio0
PE Ratio to Industry62%
Debt-Equity Ratio999,999.00%
Debt-Equity to Industry1.39%
Total Return Last 12 Months-16.67%
Total Return Last 3 Years-47.06%
Total Return Last 5 Years-96.90%
Latest Trade DateDec. 14, 2018
BTHE
Boston Therapeutics Inc Dividend Payment History

No Data available for Payment History.

BTHE
Boston Therapeutics Inc Other Details

Boston Therapeutics is a pharmaceutical company focused on the development, outsourced contract manufacture and commercialization of carbohydrate-based therapeutic drugs and dietary supplements. Co.'s primary pharmaceutical drug candidates are: BTI-320, a non-systemic, carbohydrate-based compound designed to reduce post-meal elevation of blood glucose levels in Type 2 diabetic patients, pre diabetic patients; and IPOXYN, a carbohydrate-based, injectable drug intended to prevent necrosis, or cell death, and to treat hypoxic conditions. In addition, Co. test markets and sells SUGARDOWN®, a non-systemic, carbohydrate-based dietary supplement designed to support healthy blood glucose levels.

Web Sitewww.bostonti.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Boston Therapeutics Inc Dividend Stock News and Updates

Dec. 14, 2018CLOSE PRICE INCREASE: Boston Therapeutics Inc (OTCBB: BTHE) on 12-14-2018 increased close price > 10% from $0.04 to $0.05

Read more...

Dec. 13, 2018CLOSE PRICE DECREASE: Boston Therapeutics Inc (OTCBB: BTHE) on 12-13-2018 decreased close price > 10% from $0.05 to $0.04

Read more...

Dec. 12, 2018CLOSE PRICE INCREASE: Boston Therapeutics Inc (OTCBB: BTHE) on 12-12-2018 increased close price > 10% from $0.04 to $0.05

Read more...
More Boston Therapeutics Inc Dividend News
Pharmaceuticals Dividend Stock News and Updates

Dec. 15, 201852 WEEK LOW: AXM Pharma Inc (OTCBB: AXMP) on 12-15-2018 hit a 52 week low of $0.00

Read more...

Dec. 15, 2018CLOSE PRICE DECREASE: AXM Pharma Inc (OTCBB: AXMP) on 12-15-2018 decreased close price > 10% from $0.01 to $0.00

Read more...

Dec. 15, 2018CLOSE PRICE INCREASE: Acura Pharmaceuticals Inc (OTCBB: ACUR) on 12-15-2018 increased close price > 10% from $0.15 to $0.16

Read more...
More Pharmaceuticals Dividend News
FREE REPORT
X
Bryan Perry Dividend Income Expert Bryan Perry

Earn 8% on this "Government Mandated Income Opportunity"

X

Search Dividend Investor